Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin

20 Nov 2023

Abstract excerpt

Background: Abnormal gut microbiota and blood trimethylamine-N-oxide (TMAO) metabolome have been reported in patients with type 2 diabetes mellitus (T2DM) and advanced diabetic nephropathy. This study aimed to investigate the gut microbiota profiles and a group of targeted urine metabolic characteristics in T2DM patients with or without microalbuminuria, to determine the correlation between the gut microbiota...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes
Share to Gut microbiota and health
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38075058
DOI: 10.3389/fendo.2023.1257457

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbuminPMID 38075058Read ↗

Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitusSemantic proximity Read ↗

Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes.Semantic proximity Read ↗

Trimethylamine- N -oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human bodySemantic proximity Read ↗

Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and DiseaseSemantic proximity Read ↗

Gut Microbial Genes and Metabolism for Methionine and Branched-Chain Amino Acids in Diabetic NephropathySemantic proximity Read ↗

The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.Semantic proximity Read ↗

Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic HorizonsSemantic proximity Read ↗

Altered Intestinal Microbial Flora and Abnormal Metabolism in Chinese Patients With Idiopathic Membranous NephropathySemantic proximity Read ↗

BCAA dysmetabolism in the host and gut microbiome, a key player in the development of obesity and T2DMSemantic proximity Read ↗

Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular diseaseSemantic proximity Read ↗

Analysis of Alterations in Intestinal Flora in Chinese Elderly with Cardiovascular Disease and Its Association with TrimethylamineSemantic proximity Read ↗

Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.